Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (39)
  • 2025 (69)
  • 2024 (90)
  • 2023 (75)
  • 2022 (71)
  • 2021 (56)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4320)
  • Synthetic drugs (1182)
  • Guns/Weapons (1071)
  • OCDETF/Task Force (827)
  • Fake Pills (708)
  • Arrests/Convictions - Major (688)
  • Guilty Plea (568)
  • Seizures (Drugs/Property) (508)
  • Prescription Drugs (390)
  • Overdose (336)
  • Major Law Enforcement Operation (292)
  • Diversion Division (269)
  • Take Back Day (258)
  • Task Forces/Task Force Officers (254)
  • Money Laundering (223)
  • Gangs (207)
  • Outreach/Drug Prevention (195)
  • One Pill Can Kill (124)
  • HIDTA (105)
  • Press Conferences (70)
  • Fentanyl Free America (65)
  • Counterfeit Pills (57)
  • Narcoterrorism (56)
  • Extraditions (55)
  • Prevention/Education - DEA websites GSAD, JTT etc (55)
  • Public and Media Affairs - also see Congressional Affairs (52)
  • Asset Forfeiture (31)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (29)
  • Red Ribbon (28)
  • Campaigns (18)
  • Congressional Affairs (15)
  • Other (15)
  • Terrorism (15)
  • Cartel (10)
  • Critical Incident (10)
  • Intergovernmental Affairs (9)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (238)
  • Fentanyl Awareness (180)

Drug Name

  • Fentanyl (126)
  • Opioids (50)
  • Oxycodone (49)
  • Methamphetamine (21)
  • Synthetic Opioids (17)
  • Hydromorphone (15)
  • Cocaine (12)
  • Benzodiazepines (8)
  • Heroin (8)
  • Morphine (8)
  • Marijuana (Cannabis) (4)
  • Ketamine (3)
  • Methadone (3)
  • Steroids (3)
  • Amphetamines (2)
  • Xylazine (2)
  • GHB (1)
  • Marijuana Concentrates (1)

Field Division

  • Atlanta (18)
  • Chicago (21)
  • Dallas (8)
  • El Paso (15)
  • Houston (38)
  • Los Angeles (17)
  • Louisville (23)
  • Miami (22)
  • New England (7)
  • New Jersey (14)
  • New Orleans (11)
  • New York (28)
  • Omaha (29)
  • Philadelphia (1)
  • Phoenix (7)
  • Rocky Mountain (16)
  • San Diego (6)
  • San Francisco (11)
  • Seattle (18)
  • Sede (20)
  • St. Louis (44)
  • Washington, DC (43)
Clear All Results
418 Results - Showing 161 to 170
PRESS RELEASE

Dark Web Drug Vendor and Clandestine Lab Manufacturer Sentenced to Prison for Trafficking in Meth and Fentanyl

MIAMI – On May 17, an Orange County, California, resident, Tenzin Orgil, 24, was sentenced to 168 months in federal prison for participating in a drug trafficking enterprise that included the sale of methamphetamine and fentanyl on the dark web, as well as the manufacture of ecstasy (also known as...
PRESS RELEASE

DEA Phoenix & the AZ Attorney General “Huddles Up” with NFL Alumni and Rise Up Glendale to Spread Awareness about Fentanyl

(PHOENIX) – The U.S. Drug Enforcement Administration Phoenix Division and Arizona Attorney General Kris Mayes are Huddling Up with NFL Alumni Health and Rise Up Glendale this Friday, May 17th to raise awareness and bring the community together to save lives. This community outreach and educational opportunity aims to provide...
PRESS RELEASE

Miami DEA Stress Fentanyl Dangers During Community Stakeholder Meeting

MIAMI—Drug Enforcement Administration (DEA) Miami Field Division personnel recently hosted an Operation Engage South Florida meeting with community stakeholders at First Baptist Church in Fort Lauderdale, Fla., to stress the dangers of fentanyl—especially regarding children. Operation Engage South F lorida is an opportunity to keep fentanyl prevention, awareness, and education...
PRESS RELEASE

Operation Cash Out Launched Across Colorado, Utah, Wyoming, Montana

DENVER – Fentanyl continues to be the leading cause of death for Americans between the ages of 18 and 45. In 2023, the Drug Enforcement Administration (DEA) seized nationally more than 77 million fentanyl pills and nearly 12,000 pounds of fentanyl powder. Across the DEA Rocky Mountain Field Division –...
PRESS RELEASE

DEA Rocky Mountain Field Division Recognizes National Fentanyl Awareness Day

Today, May 7, 2024 is National Fentanyl Awareness Day. This annual observance is held to bring needed attention and awareness to the threats from fentanyl and fake pills – and the lives lost to poisonings and overdoses. Fentanyl is the most significant drug threat the United States has faced in...
PRESS RELEASE

DEA Recognizes National Fentanyl Awareness Day

WASHINGTON – DEA is proud to join “Song for Charlie” and many of our valued law enforcement, public health, and non-profit partners in recognizing National Fentanyl Awareness Day. Tomorrow represents an important opportunity to honor those we’ve lost to fentanyl poisonings by educating others about the deadly threat of this...
PRESS RELEASE

Operation Hotline Bling

LOS ANGELES – The Drug Enforcement Administration Los Angeles Field Division today announced the results of a multi-agency investigation targeting a Sinaloa drug trafficking network operating within the Inland Empire. Operation “Hotline Bling,” which started in early 2023, culminated last week with 15 arrests and significant drug seizures, including methamphetamine...
PRESS RELEASE

Anesthesiologist Pleads Guilty to Taking Fentanyl from Hospital

KANSAS CITY, Mo. – An anesthesiologist at a Lee’s Summit, Mo., hospital pleaded guilty in federal court today to illegally taking prescription fentanyl from the hospital. Roman Peplinski, 37, of Kansas City, Mo., waived his right to a grand jury and pleaded guilty before U.S. District Judge Greg Kays to...
PRESS RELEASE

DEA Rocky Mountain Field Division Encourages Prescription Take Back This Saturday

The Drug Enforcement Administration’s Rocky Mountain Field Division (RMFD) is proud to be part of the 26th annual National Prescription Drug Take Back Day this Saturday, April 27, 2024 from 10:00am to 2:00pm MST at dozens of locations across Colorado, Utah, Wyoming and Montana. “DEA’s Take Back events serve as...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...

Paginación

  • Primera página «
  • Anterior
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster